Lipodystrophy is a problem with the way your body makes, uses, and stores fat. It's also called fat redistribution. While it used to be more common with older antiretroviral (ART) treatments for ...

NEW YORK, 26 July (Praxis Press) The human immunodeficiency virus (HIV) lipodystrophy syndrome is characterized by fat redistribution and insulin resistance; this syndrome is particularly common among ...

Novelion Therapeutics’ Myalepta (metreleptin) developed for the ultra-rare condition lipodystrophy has been approved by the European Commission, giving patients the first treatment to improve ...

Congenital generalized lipodystrophy (CGL), which affects only a few thousand people worldwide, results in severe metabolic disease, diabetes, insulin resistance and reduced life expectancy. With ...

Researchers from the Rutgers Robert Wood Johnson Medical School and the Children's Hospital of Orange County discovered a ...

Congenital generalized lipodystrophy (CGL), which affects only a few thousand people worldwide, results in severe metabolic disease, diabetes, insulin resistance and reduced life expectancy. With ...

Entos Pharmaceuticals Inc. has been awarded a $4 million grant by California Institute for Regenerative Medicine (CIRM) to support the completion of IND-enabling activities with ENTLEP-001, a durable ...

CIRM awards US$ 4 mn grant to Entos Pharma to advance development of ENTLEP001, a durable and redosable genetic medicine to treat CGL: San Diego Friday, February 7, 2025, 15:00 Hr ...

Lipodystrophy is a side-effect of some anti-HIV drugs. These are mainly older drugs which are now rarely used. Lipodystrophy may include an accumulation of fat, a loss of fat, or both. It is common ...